COLUMN. Two economists have sought to determine the impact of the opioid crisis in the US. They found that in areas hit hard ...

With over 200,000 opioid-related deaths in the U.S. alone, the Sackler family has come under intense scrutiny for their role ...

Among other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...

An investigation into the agency’s repeated violations of its own rules to approve addictive drugs—and its ongoing failure to ...

Members of the family who own OxyContin maker Purdue Pharma have agreed to pay up to 7.4 billion dollars (£6 billion) in a new settlement to lawsuits over the toll of the powerful prescription ...

OxyContin maker Purdue Pharma sent $12 billion or $13 billion in profits to members of the Sackler family who own the company, according to court records and testimony filed in the drugmaker’s ...

They deny wrongdoing and stopped short of offering an apology for the impact of Purdue Pharma's involvement in the opioid market, centred around the promotion and marketing of its OxyContin ...

John McNerney was told his Purdue Pharma claim didn't qualify, because he hadn't been prescribed enough OxyContin to meet the threshold. He submitted claims for Mallinckrodt and Endo instead.

A federal prosecutor in Boston who investigated the compounding pharmacy behind a deadly 2012 U.S. fungal meningitis outbreak and more recently prosecuted consulting firm McKinsey & Co for its role in ...